RxDoctor Payments Data

Priyanka Gupta, MD

Urogynecology and Reconstructive Pelvic Surgery · Ann Arbor, MINPI 1174758262

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 90.2% of it on its own, with 7 other manufacturers making up the rest. Among urogynecology and reconstructive pelvic surgery clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,203in general payments, 2019–2025

Across 51 payments — averaging $768.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$35K
  • Medtronic$3K
  • Boston Scientific$427
  • Axonics, Inc.$200
  • Bard Peripheral Vascular, Inc.$130
  • Palette Life Sciences, Inc.$90
  • plus $43 from 2 others
$343,365in research payments, 2019–2025

Across 10 payments — averaging $34,337 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$343K

What the payments were for

  • Consulting fees$17,33844%
  • Speaking & faculty fees$16,44542%
  • Grants$1,0503%
  • Travel & lodging$2,2326%
  • Food & beverage$2,1395%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,203 in reported general payments places this provider in the 90th percentile of 33 urogynecology and reconstructive pelvic surgery providers in Michigan.

See all urogynecology and reconstructive pelvic surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$76,215
Medicare patients
255
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron230$166,048
Mirabegron ErMirabegron38$23,282
Trospium Chloride ErTrospium Chloride94$17,674
GemtesaVibegron20$12,360
Estradiol173$9,734
Gentamicin Sulfate108$4,210
Trospium Chloride45$4,039
Methenamine Hippurate34$3,004
Tamsulosin Hcl40$956
Sodium ChlorideSodium Chloride Irrig Solution42$391
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$316
Imipramine Hcl13$265
Hydroxyzine Hcl25$228
Cephalexin31$115
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$27

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →